ROTHBLATT MARTINE A

SEC CIK
0001106578

在各公司的最新職務

交易紀錄

所有把 ROTHBLATT MARTINE A 列為申報人的 Form 4,包括與他人共同申報的。每一列是一份申報裡同一種交易的合計;預設只顯示公開市場買進(P)與賣出(S)。

內部人交易
公司申報時間(美東)交易日內部人交易股數均價金額交易後持股持股變化申報
UTHRUNITED THERAPEUTICS Corp2026/9/2516:31 ET2026/9/24ROTHBLATT MARTINE A董事長、執行長S賣出Common Stock−9,500$473.5529−$449.88 萬32.44 萬−2.8%SEC10b5-1
UTHRUNITED THERAPEUTICS Corp2026/9/2416:31 ET2026/9/23ROTHBLATT MARTINE A董事長、執行長S賣出Common Stock−9,500$491.5703−$466.99 萬32.44 萬−2.8%SEC10b5-1
UTHRUNITED THERAPEUTICS Corp2026/9/2316:30 ET2026/9/22ROTHBLATT MARTINE A董事長、執行長S賣出Common Stock−9,500$494.8264−$470.09 萬32.44 萬−2.8%SEC10b5-1
UTHRUNITED THERAPEUTICS Corp2026/9/2216:33 ET2026/9/21ROTHBLATT MARTINE A董事長、執行長S賣出Common Stock−9,500$494.5548−$469.83 萬32.44 萬−2.8%SEC10b5-1
UTHRUNITED THERAPEUTICS Corp2026/9/2116:44 ET2026/9/18ROTHBLATT MARTINE A董事長、執行長S賣出Common Stock−9,500$494.79−$470.05 萬32.44 萬−2.8%SEC10b5-1
UTHRUNITED THERAPEUTICS Corp2026/9/1816:41 ET2026/9/17ROTHBLATT MARTINE A董事長、執行長S賣出Common Stock−9,500$496.0611−$471.26 萬32.44 萬−2.8%SEC10b5-1
UTHRUNITED THERAPEUTICS Corp2026/9/1716:43 ET2026/9/16ROTHBLATT MARTINE A董事長、執行長S賣出Common Stock−9,500$501.3865−$476.32 萬32.44 萬−2.8%SEC10b5-1
UTHRUNITED THERAPEUTICS Corp2026/9/1616:35 ET2026/9/15ROTHBLATT MARTINE A董事長、執行長S賣出Common Stock−9,500$501.5915−$476.51 萬32.44 萬−2.8%SEC10b5-1
UTHRUNITED THERAPEUTICS Corp2026/9/1516:34 ET2026/9/14ROTHBLATT MARTINE A董事長、執行長S賣出Common Stock−9,500$504.1213−$478.92 萬32.44 萬−2.8%SEC10b5-1
UTHRUNITED THERAPEUTICS Corp2026/9/1416:43 ET2026/9/11ROTHBLATT MARTINE A董事長、執行長S賣出Common Stock−9,500$500.8182−$475.78 萬32.44 萬−2.8%SEC10b5-1
UTHRUNITED THERAPEUTICS Corp2026/9/1116:34 ET2026/9/10ROTHBLATT MARTINE A董事長、執行長S賣出Common Stock−9,500$502.3469−$477.23 萬32.44 萬−2.8%SEC10b5-1
UTHRUNITED THERAPEUTICS Corp2026/9/1016:31 ET2026/9/9ROTHBLATT MARTINE A董事長、執行長S賣出Common Stock−9,500$501.8387−$476.75 萬32.44 萬−2.8%SEC10b5-1
UTHRUNITED THERAPEUTICS Corp2026/9/916:33 ET2026/9/8ROTHBLATT MARTINE A董事長、執行長S賣出Common Stock−9,500$499.0311−$474.08 萬32.44 萬−2.8%SEC10b5-1
UTHRUNITED THERAPEUTICS Corp2026/9/816:31 ET2026/9/4ROTHBLATT MARTINE A董事長、執行長S賣出Common Stock−9,500$489.1952−$464.74 萬32.44 萬−2.8%SEC10b5-1
UTHRUNITED THERAPEUTICS Corp2026/9/416:31 ET2026/9/3ROTHBLATT MARTINE A董事長、執行長S賣出Common Stock−9,500$487.5389−$463.16 萬32.44 萬−2.8%SEC10b5-1
UTHRUNITED THERAPEUTICS Corp2026/9/316:31 ET2026/9/2ROTHBLATT MARTINE A董事長、執行長S賣出Common Stock−9,500$493.457−$468.78 萬32.44 萬−2.8%SEC10b5-1
UTHRUNITED THERAPEUTICS Corp2026/9/216:34 ET2026/9/1ROTHBLATT MARTINE A董事長、執行長S賣出Common Stock−9,500$514.0884−$488.38 萬32.44 萬−2.8%SEC10b5-1
UTHRUNITED THERAPEUTICS Corp2026/9/116:33 ET2026/8/31ROTHBLATT MARTINE A董事長、執行長S賣出Common Stock−9,500$511.0855−$485.53 萬32.44 萬−2.8%SEC10b5-1
UTHRUNITED THERAPEUTICS Corp2026/8/3116:34 ET2026/8/28ROTHBLATT MARTINE A董事長、執行長S賣出Common Stock−9,500$517.5119−$491.64 萬32.44 萬−2.8%SEC10b5-1
UTHRUNITED THERAPEUTICS Corp2026/8/2816:30 ET2026/8/27ROTHBLATT MARTINE A董事長、執行長S賣出Common Stock−9,500$522.5659−$496.44 萬32.44 萬−2.8%SEC10b5-1
UTHRUNITED THERAPEUTICS Corp2026/8/2716:34 ET2026/8/26ROTHBLATT MARTINE A董事長、執行長S賣出Common Stock−9,500$517.2831−$491.42 萬32.44 萬−2.8%SEC10b5-1
UTHRUNITED THERAPEUTICS Corp2026/8/2616:30 ET2026/8/25ROTHBLATT MARTINE A董事長、執行長S賣出Common Stock−9,500$517.713−$491.83 萬32.44 萬−2.8%SEC10b5-1
UTHRUNITED THERAPEUTICS Corp2026/8/2516:38 ET2026/8/24ROTHBLATT MARTINE A董事長、執行長S賣出Common Stock−9,500$511.9716−$486.37 萬32.44 萬−2.8%SEC10b5-1
UTHRUNITED THERAPEUTICS Corp2026/8/2416:30 ET2026/8/21ROTHBLATT MARTINE A董事長、執行長S賣出Common Stock−9,500$518.3859−$492.47 萬32.44 萬−2.8%SEC10b5-1
UTHRUNITED THERAPEUTICS Corp2026/8/2116:44 ET2026/8/20ROTHBLATT MARTINE A董事長、執行長S賣出Common Stock−9,500$521.0228−$494.97 萬32.44 萬−2.8%SEC10b5-1
UTHRUNITED THERAPEUTICS Corp2026/8/2016:37 ET2026/8/19ROTHBLATT MARTINE A董事長、執行長S賣出Common Stock−9,500$526.9583−$500.61 萬32.44 萬−2.8%SEC10b5-1
UTHRUNITED THERAPEUTICS Corp2026/8/1916:33 ET2026/8/18ROTHBLATT MARTINE A董事長、執行長S賣出Common Stock−9,500$515.6022−$489.82 萬32.44 萬−2.8%SEC10b5-1
UTHRUNITED THERAPEUTICS Corp2026/8/1816:31 ET2026/8/17ROTHBLATT MARTINE A董事長、執行長S賣出Common Stock−9,500$506.5861−$481.26 萬32.44 萬−2.8%SEC10b5-1
UTHRUNITED THERAPEUTICS Corp2026/8/1716:34 ET2026/8/14ROTHBLATT MARTINE A董事長、執行長S賣出Common Stock−9,500$498.912−$473.97 萬32.44 萬−2.8%SEC10b5-1
UTHRUNITED THERAPEUTICS Corp2026/8/1416:41 ET2026/8/13ROTHBLATT MARTINE A董事長、執行長S賣出Common Stock−9,500$504.2438−$479.03 萬32.44 萬−2.8%SEC10b5-1
UTHRUNITED THERAPEUTICS Corp2026/8/1317:09 ET2026/8/12ROTHBLATT MARTINE A董事長、執行長S賣出Common Stock−9,500$515.0261−$489.27 萬32.44 萬−2.8%SEC10b5-1
UTHRUNITED THERAPEUTICS Corp2026/8/1216:30 ET2026/8/11ROTHBLATT MARTINE A董事長、執行長S賣出Common Stock−9,500$522.8728−$496.73 萬32.44 萬−2.8%SEC10b5-1
UTHRUNITED THERAPEUTICS Corp2026/8/1116:30 ET2026/8/10ROTHBLATT MARTINE A董事長、執行長S賣出Common Stock−9,500$530.113−$503.61 萬32.44 萬−2.8%SEC10b5-1
UTHRUNITED THERAPEUTICS Corp2026/8/1016:38 ET2026/8/7ROTHBLATT MARTINE A董事長、執行長S賣出Common Stock−9,500$531.3829−$504.81 萬32.44 萬−2.8%SEC10b5-1
UTHRUNITED THERAPEUTICS Corp2026/8/716:30 ET2026/8/6ROTHBLATT MARTINE A董事長、執行長S賣出Common Stock−9,500$525.3551−$499.09 萬32.44 萬−2.8%SEC10b5-1
UTHRUNITED THERAPEUTICS Corp2026/8/616:34 ET2026/8/5ROTHBLATT MARTINE A董事長、執行長S賣出Common Stock−9,500$518.7353−$492.8 萬32.44 萬−2.8%SEC10b5-1
UTHRUNITED THERAPEUTICS Corp2026/8/516:36 ET2026/8/4ROTHBLATT MARTINE A董事長、執行長S賣出Common Stock−9,500$517.0853−$491.23 萬32.44 萬−2.8%SEC10b5-1
UTHRUNITED THERAPEUTICS Corp2026/8/416:32 ET2026/8/3ROTHBLATT MARTINE A董事長、執行長S賣出Common Stock−9,500$516.0599−$490.26 萬32.44 萬−2.8%SEC10b5-1
UTHRUNITED THERAPEUTICS Corp2026/8/316:32 ET2026/7/31ROTHBLATT MARTINE A董事長、執行長S賣出Common Stock−9,500$518.9577−$493.01 萬32.44 萬−2.8%SEC10b5-1
UTHRUNITED THERAPEUTICS Corp2026/7/3116:18 ET2026/7/30ROTHBLATT MARTINE A董事長、執行長S賣出Common Stock−9,500$524.9046−$498.66 萬32.44 萬−2.8%SEC10b5-1
UTHRUNITED THERAPEUTICS Corp2026/7/3007:58 ET2026/7/29ROTHBLATT MARTINE A董事長、執行長S賣出Common Stock−9,500$522.3671−$496.25 萬32.44 萬−2.8%SEC10b5-1
UTHRUNITED THERAPEUTICS Corp2026/7/2818:19 ET2026/7/28ROTHBLATT MARTINE A董事長、執行長S賣出Common Stock−9,500$526.7343−$500.4 萬32.44 萬−2.8%SEC10b5-1
UTHRUNITED THERAPEUTICS Corp2026/7/2721:36 ET2026/7/27ROTHBLATT MARTINE A董事長、執行長S賣出Common Stock−9,500$530.418−$503.9 萬32.44 萬−2.8%SEC10b5-1
UTHRUNITED THERAPEUTICS Corp2026/7/2706:55 ET2026/7/24ROTHBLATT MARTINE A董事長、執行長S賣出Common Stock−9,500$531.7388−$505.15 萬32.44 萬−2.8%SEC10b5-1
UTHRUNITED THERAPEUTICS Corp2026/7/2416:30 ET2026/7/23ROTHBLATT MARTINE A董事長、執行長S賣出Common Stock−9,500$528.581−$502.15 萬32.44 萬−2.8%SEC10b5-1
UTHRUNITED THERAPEUTICS Corp2026/7/2316:36 ET2026/7/22ROTHBLATT MARTINE A董事長、執行長S賣出Common Stock−9,500$530.5663−$504.04 萬32.44 萬−2.8%SEC10b5-1
UTHRUNITED THERAPEUTICS Corp2026/7/2216:30 ET2026/7/21ROTHBLATT MARTINE A董事長、執行長S賣出Common Stock−9,500$532.2419−$505.63 萬32.44 萬−2.8%SEC10b5-1
UTHRUNITED THERAPEUTICS Corp2026/7/2116:35 ET2026/7/20ROTHBLATT MARTINE A董事長、執行長S賣出Common Stock−9,500$531.6879−$505.1 萬32.44 萬−2.8%SEC10b5-1
UTHRUNITED THERAPEUTICS Corp2026/7/2016:32 ET2026/7/17ROTHBLATT MARTINE A董事長、執行長S賣出Common Stock−9,500$537.0463−$510.19 萬32.44 萬−2.8%SEC10b5-1
UTHRUNITED THERAPEUTICS Corp2026/7/1716:30 ET2026/7/16ROTHBLATT MARTINE A董事長、執行長S賣出Common Stock−9,500$530.9146−$504.37 萬32.44 萬−2.8%SEC10b5-1